AGNIESZKA HASS: Open Payments
NPI 1396392460 · ROSELLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 22 payments from 8 companies in 2025. Trend: 2023 $836 · 2024 $769 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 4 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $103 |
| PFIZER INC. | 3 | $66 |
| Amgen Inc. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: FUROSCIX, JARDIANCE, ELIQUIS, REPATHA, VERQUVO, LifeVest, LOKELMA, LEQVIO.
Industry payments across NJ — which companies pay providers there.
